Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data

Authors
Category Primary study
JournalNauchno-Prakticheskaya Revmatologiya
Year 2025
This article has no abstract
Epistemonikos ID: 15ec9c92c3aad8782970eeba8f291733e6d9fe1b
First added on: Apr 29, 2026